Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, Finland.
Drug Metab Dispos. 2012 Oct;40(10):1935-44. doi: 10.1124/dmd.112.046086. Epub 2012 Jul 10.
Many laboratories use recombinant UDP-glucuronosyltransferases (UGTs), expressed in baculovirus-infected insect cells, for drug glucuronidation studies. We have infected Sf9 insect cells with increasing amounts of recombinant baculovirus, encoding either UGT1A9 or UGT2B7, and measured both glucuronidation activity and immunodetectable UGT in the resulting cell homogenates. The correlation between glucuronidation rates and degree of infection followed different trends, depending on whether activity was the actual activity measured or was corrected for UGT expression level. Above a certain low level of infection, further increases in infection ratios led to a large decline in normalized activity, presumably due to the presence of full-length but inactive enzyme in the sample. Because immunodetection does not distinguish between active and inactive UGT, comparison of normalized activity between different batches of a recombinant UGT, mutants of a given UGT, or different UGTs is prone to large inaccuracies. Such inaccuracies could be reduced by lowering the degree of infection of the insect cells, in combination with careful monitoring of UGT expression. However, the latter requires suitable antibodies for comparing UGT expression levels among preparations, antibodies that are not always available. Poly-His (His-tag)-containing peptides, fused to the UGT C terminus, allow sensitive immunodetection of expressed enzymes with monoclonal antibodies. We have now carefully examined the effects of two such fusion peptides on enzyme kinetics. A minor increase in the K(m) values has been detected in the His-tagged UGTs, but no changes in parameters such as the kinetic model and the effects of albumin addition.
许多实验室使用重组 UDP-葡糖醛酸基转移酶(UGTs),在杆状病毒感染的昆虫细胞中表达,进行药物葡醛酸化研究。我们用编码 UGT1A9 或 UGT2B7 的重组杆状病毒感染 Sf9 昆虫细胞,测量所得细胞匀浆中的葡醛酸化活性和可免疫检测的 UGT。葡醛酸化速率与感染程度之间的相关性呈现出不同的趋势,具体取决于所测活性是实际活性还是校正了 UGT 表达水平。在一定的低感染水平之上,进一步增加感染比率会导致归一化活性的大幅下降,这可能是由于样品中存在全长但无活性的酶。因为免疫检测无法区分有活性和无活性的 UGT,所以在比较不同批次的重组 UGT、特定 UGT 的突变体或不同 UGT 之间的归一化活性时,很容易出现较大的误差。通过降低昆虫细胞的感染程度,并结合对 UGT 表达的仔细监测,可以减少这种误差。然而,后者需要合适的抗体来比较制剂之间的 UGT 表达水平,而这些抗体并非总是可用的。含有多组氨酸(His 标签)的肽与 UGT C 端融合,允许使用单克隆抗体对表达的酶进行敏感的免疫检测。我们现在已经仔细研究了这两种融合肽对酶动力学的影响。在 His 标记的 UGT 中检测到了 K(m)值的轻微增加,但参数如动力学模型和白蛋白添加的影响没有变化。